Münster, Germany

Klaus Kopka

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Munster, DE (2012)
  • Münster, DE (2012 - 2013)

Company Filing History:


Years Active: 2012-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Klaus Kopka: Innovator in Diagnostic Imaging

Introduction

Klaus Kopka is a notable inventor based in Münster, Germany. He has made significant contributions to the field of diagnostic imaging, holding a total of 3 patents. His work focuses on developing innovative compounds that enhance diagnostic techniques and improve patient outcomes.

Latest Patents

Klaus Kopka's latest patents include the development of novel 5-pyrrolidinylsulfonyl isatin derivatives. This invention relates to non-peptidyl Caspase binding Radioligands (CbRs) and CbR-transporter conjugates derived from these isatin derivatives. These compounds are designed for use in non-invasive diagnostic imaging. Another significant patent involves diagnostic imaging agents with matrix metalloproteinase (MMP) inhibitory activity. This invention aims to improve the diagnostic imaging of diseases associated with specific MMPs, providing a pharmaceutical composition suitable for mammalian administration.

Career Highlights

Throughout his career, Klaus Kopka has worked with prominent organizations such as GE Healthcare Limited and Universitätsklinikum Münster. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative diagnostic solutions.

Collaborations

Klaus has collaborated with notable professionals in his field, including Michael Schäfers and Anthony Eamon Storey. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Klaus Kopka's contributions to diagnostic imaging through his innovative patents and collaborations highlight his role as a key figure in the field. His work continues to influence advancements in medical diagnostics, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…